Stillpoint founder Eric Wong reveals major China tech investment strategy

Eric Wong will present his investment case at the Sohn Hearts & Minds conference at the Sydney Opera House on Friday, November 14.
Stillpoint Investments founder and chief investment officer Eric Wong. Picture: Jaclyn Licht

David Rogers

Stillpoint founder Eric Wong reveals major China tech investment strategy

September 25, 2025
Eric Wong will present his investment case at the Sohn Hearts & Minds conference at the Sydney Opera House on Friday, November 14.
Read Transcript

Eric Wong has seen plenty of market cycles. The founder of Stillpoint Investments cut his teeth during the global financial crisis, working for legendary hedge fund manager John Griffin at Blue Ridge Capital, himself a protégé of the great Julian Robertson of Tiger Management.

Now Wong is betting big on China. His Greater China equity fund is capitalising on what he sees as a once-in-a-decade opportunity as Chinese tech stocks surge from bargain valuation levels.

“China’s markets continue to trade at a meaningful discount to the S&P,” Wong says. “It’s trading at a PE ratio of 12 to 13 times, whereas the US is approaching the mid-20s. From a cash flow yield perspective, China’s trading at seven-plus per cent and the US is at slightly less than three per cent.”

“You almost are able to get a 50 per cent discount on the broader market.”

Wong spent 11 years at Blue Ridge Capital, where Griffin built a track record of 15.4 per cent annual returns over two decades. Griffin’s influence on Wong went beyond just investing.

“His influence on me has been holistic in so many different ways, beyond just investing — thinking about life and wellness and how that actually enhances how we think about the investment landscape,” Wong tells The Australian.

The experience shaped Wong’s approach at Stillpoint, which he founded in 2022.

Like his mentor, Wong is a generalist who goes where the opportunities are richest.

Currently, that’s artificial intelligence infrastructure in China. The numbers are staggering.

“What we’re seeing happening in China is the hyperscalers, like the ByteDances and the Alibabas, are actually expanding their AI infrastructure capital expenditure dramatically,” Wong says.

“This year, the broader capex is going up by 60 per cent year-on-year.”

These data centre companies are trading at just 12 to 13 times EBITDA, compared to their global peers at well above 20 times.

The geopolitical headlines around chip bans have also created opportunities.

“The news around the chip bans will create uncertainty from market perception in terms of how sustainable this growth is,” he says. “But, from our perspective, it’s more around the matter of which chips they use. They will still need the data centres.”

Wong’s second major theme is precision manufacturing. Companies operating in the space help expand manufacturing capacity outside China as supply chains reshape in an increasingly multipolar world.

“These are businesses that are actually helping expand manufacturing capacity in markets outside of China,” he says. “When you think about the reshaping of what manufacturing looks like in a more de-globalised world, these businesses are actually in a position to benefit during this geopolitical tension.”

These companies trade at single-digit price-to-earnings multiples and pay dividend yields of eight to nine per cent. His conviction comes from seeing China’s technological advancement first-hand during his frequent visits. While based in New York City, Wong spends about a third of his time in China.

The technology integration into daily life is remarkable. At hotels, robots deliver room service from ground-floor cabinets to guest rooms. Hotel TVs show real-time availability of washing machines so guests don’t waste trips to the laundry.

“I think what I’m trying to illustrate is that the ease of life that is brought by technology, even in the simplest ways, helps improve efficiency and lower inconvenience,” Wong says.

“These types of use cases from a consumer perspective are actually very present in day-to-day life.”

As evidence the long winter for Chinese equities may be ending, he notes southbound liquidity flowing into Hong Kong this year has already surpassed all of 2024. IPO activity has also picked up and margin trading is increasing sustainably.

Most tellingly, Chinese household deposits fell for two consecutive months recently, with money shifting into equity markets.

“I’ve always viewed that this closing of winter in Chinese equity markets needs to be led by the domestic investor,” Wong says. For global investors, Wong believes China simply can’t be ignored.

“It’s a market you can’t ignore — second largest economy in the world. It’s a place that I think every investor has to visit, at the very least. From an allocation perspective, what we’ve seen over recent years in terms of foreign capital fleeing, I think that’s certainly worth revisiting.”

Eric Wong will present his investment case at the Sohn Hearts & Minds conference at the Sydney Opera House on Friday, November 14, 2025.

The annual conference features stock picks from leading global investment experts, with all profits donated to medical research.

This year marks 10 years of the conference, which has raised over $83.7m.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Eric Wong has seen plenty of market cycles. The founder of Stillpoint Investments cut his teeth during the global financial crisis, working for legendary hedge fund manager John Griffin at Blue Ridge Capital, himself a protégé of the great Julian Robertson of Tiger Management.

Now Wong is betting big on China. His Greater China equity fund is capitalising on what he sees as a once-in-a-decade opportunity as Chinese tech stocks surge from bargain valuation levels.

“China’s markets continue to trade at a meaningful discount to the S&P,” Wong says. “It’s trading at a PE ratio of 12 to 13 times, whereas the US is approaching the mid-20s. From a cash flow yield perspective, China’s trading at seven-plus per cent and the US is at slightly less than three per cent.”

“You almost are able to get a 50 per cent discount on the broader market.”

Wong spent 11 years at Blue Ridge Capital, where Griffin built a track record of 15.4 per cent annual returns over two decades. Griffin’s influence on Wong went beyond just investing.

“His influence on me has been holistic in so many different ways, beyond just investing — thinking about life and wellness and how that actually enhances how we think about the investment landscape,” Wong tells The Australian.

The experience shaped Wong’s approach at Stillpoint, which he founded in 2022.

Like his mentor, Wong is a generalist who goes where the opportunities are richest.

Currently, that’s artificial intelligence infrastructure in China. The numbers are staggering.

“What we’re seeing happening in China is the hyperscalers, like the ByteDances and the Alibabas, are actually expanding their AI infrastructure capital expenditure dramatically,” Wong says.

“This year, the broader capex is going up by 60 per cent year-on-year.”

These data centre companies are trading at just 12 to 13 times EBITDA, compared to their global peers at well above 20 times.

The geopolitical headlines around chip bans have also created opportunities.

“The news around the chip bans will create uncertainty from market perception in terms of how sustainable this growth is,” he says. “But, from our perspective, it’s more around the matter of which chips they use. They will still need the data centres.”

Wong’s second major theme is precision manufacturing. Companies operating in the space help expand manufacturing capacity outside China as supply chains reshape in an increasingly multipolar world.

“These are businesses that are actually helping expand manufacturing capacity in markets outside of China,” he says. “When you think about the reshaping of what manufacturing looks like in a more de-globalised world, these businesses are actually in a position to benefit during this geopolitical tension.”

These companies trade at single-digit price-to-earnings multiples and pay dividend yields of eight to nine per cent. His conviction comes from seeing China’s technological advancement first-hand during his frequent visits. While based in New York City, Wong spends about a third of his time in China.

The technology integration into daily life is remarkable. At hotels, robots deliver room service from ground-floor cabinets to guest rooms. Hotel TVs show real-time availability of washing machines so guests don’t waste trips to the laundry.

“I think what I’m trying to illustrate is that the ease of life that is brought by technology, even in the simplest ways, helps improve efficiency and lower inconvenience,” Wong says.

“These types of use cases from a consumer perspective are actually very present in day-to-day life.”

As evidence the long winter for Chinese equities may be ending, he notes southbound liquidity flowing into Hong Kong this year has already surpassed all of 2024. IPO activity has also picked up and margin trading is increasing sustainably.

Most tellingly, Chinese household deposits fell for two consecutive months recently, with money shifting into equity markets.

“I’ve always viewed that this closing of winter in Chinese equity markets needs to be led by the domestic investor,” Wong says. For global investors, Wong believes China simply can’t be ignored.

“It’s a market you can’t ignore — second largest economy in the world. It’s a place that I think every investor has to visit, at the very least. From an allocation perspective, what we’ve seen over recent years in terms of foreign capital fleeing, I think that’s certainly worth revisiting.”

Eric Wong will present his investment case at the Sohn Hearts & Minds conference at the Sydney Opera House on Friday, November 14, 2025.

The annual conference features stock picks from leading global investment experts, with all profits donated to medical research.

This year marks 10 years of the conference, which has raised over $83.7m.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on Sep 25, 2025. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
October 8, 2024

Sumit Gautam - Why AI won't deliver in 2025 | Scalar Gauge

Sumit Gautam is the Founder of Scalar Gauge and speaks with Equity Mates ahead of his appearance at the Sohn Hearts & Minds conference.

Read More
September 30, 2024

Missed out on Nvidia and Ozempic? This fundie says it’s never too late

Northcape Capital’s Fleur Wright is still kicking herself for not owning market darlings Nvidia and Novo Nordisk, the maker of the weight loss wonder drug Ozempic, before shares of those companies rocketed in 2023.

Read More
September 23, 2024

Scalar Gauge Fund founder Sumit Gautam cautious about over-hyped AI

Tech investor Sumit Gautam carefully avoids the word bubble when describing the investor frenzy surrounding the rise of artificial intelligence, but warns there are dangers of getting caught up in the hype.

Read More
September 9, 2024

The Wellcome Trust’s Nick Moakes made a 100-year bet. It’s paying off

Chief Investment Officer, Nick Moakes raised almost $3 billion at ultra-low rates. Sometimes the long view can be the most profitable.

Read More
Wellcome Trust chief investment officer Nicholas Moakes. Picture: Steven PocockWellcome Trust chief investment officer Nicholas Moakes. Picture: Steven PocockWellcome Trust chief investment officer Nicholas Moakes. Picture: Steven PocockWellcome Trust chief investment officer Nicholas Moakes. Picture: Steven Pocock
September 5, 2024

Honesty the only policy that matters, says Wellcome Trust’s Nicholas Moakes

The chief investment officer of the London-based $71bn Wellcome Trust, Nick Moakes, has a simple rule for the trust’s investment team: “Never invest with anyone who is or has been or should have been in prison.”

Read More
September 5, 2024

Why Howard Marks says you’re making a big mistake

Howard Marks says investors must ignore manic depressive markets and focus on the bigger picture. Rates will be higher for longer and that will bring pain – and opportunity.

Read More
July 21, 2024

Investors ‘comfortable’ about a Trump presidency, despite volatility

Economists and market experts say the outcome of the US presidential election has been largely priced in by investors as softening inflation helps to buoy sharemarkets both globally and locally.

Read More
February 15, 2024

Hedge fund Munro says Nvidia, Microsoft have more to run

Kieran Moore is portfolio manager of Munro Partners Global Growth Fund. The Melbourne-based hedge fund oversees $4.3 billion in assets.

Read More
January 24, 2024

How To Master The Art Of Winning The Room

Jonathan Pease, the creative director behind the Sohn Hearts & Minds Conference and author of the book, Winning the Room, recently sat down for a chat with Mark Bouris on Straight Talk.

Read More
November 19, 2023

Equity Mates review the stocks pitched at the Sohn Hearts & Minds Conference

Bryce and Ren of Equity Mates attended the Sohn Hearts & Minds Conference and reviewed the stocks pitched by our new 2023 Conference Fund Managers.

Read More
Ark Invest CEO Cathie Wood remains as big-picture as ever. Picture: David RoweArk Invest CEO Cathie Wood remains as big-picture as ever. Picture: David RoweArk Invest CEO Cathie Wood remains as big-picture as ever. Picture: David RoweArk Invest CEO Cathie Wood remains as big-picture as ever. Picture: David Rowe
November 17, 2023

‘I Know It Sounds Crazy’: Cathie Wood’s Next Big Idea

Speaking from Ark’s headquarters in Florida ahead of her appearance at the Sohn Hearts & Minds Conference on Friday, Wood says she believes disinflation is now just around the corner in the US.

Read More
ARK Invest founder Cathie Wood: It does appear that the SEC here in the United States is likely to approve a spot bitcoin ETF within the next few months.ARK Invest founder Cathie Wood: It does appear that the SEC here in the United States is likely to approve a spot bitcoin ETF within the next few months.ARK Invest founder Cathie Wood: It does appear that the SEC here in the United States is likely to approve a spot bitcoin ETF within the next few months.ARK Invest founder Cathie Wood: It does appear that the SEC here in the United States is likely to approve a spot bitcoin ETF within the next few months.
November 17, 2023

ARK Founder Wood Backs Bitcoin, Banking On Spot ETF Approval

Tech investment guru Cathie Wood is still a big believer in bitcoin, so it was fitting that she chose Grayscale Bitcoin Trust as her stock pick for the 2023 Sohn Hearts & Minds Investment Leaders Conference.

Read More
IFM Investors small cap specialist Rikki Bannan addresses the Sohn Hearts & Minds Investment Leaders Conference at Sydney Opera House. Picture: Renee NowytargerIFM Investors small cap specialist Rikki Bannan addresses the Sohn Hearts & Minds Investment Leaders Conference at Sydney Opera House. Picture: Renee NowytargerIFM Investors small cap specialist Rikki Bannan addresses the Sohn Hearts & Minds Investment Leaders Conference at Sydney Opera House. Picture: Renee NowytargerIFM Investors small cap specialist Rikki Bannan addresses the Sohn Hearts & Minds Investment Leaders Conference at Sydney Opera House. Picture: Renee Nowytarger
November 17, 2023

Hot Stocks To Ride The Next Healthcare Trends

Healthcare stocks – from sleep apnoea giant ResMed, to cancer diagnostic biotech Telix Pharmaceuticals – were recommended at the Sohn Hearts & Minds Investment Leaders Conference on Friday.

Read More
November 17, 2023

How Daniel Loeb, The Real Bobby Axelrod, Made His Wall Street Billions

When Damian Lewis, the actor who plays the ruthless hedge fund boss in the drama series Billions was looking for inspiration, he sat down with Daniel Loeb.

Read More
November 17, 2023

The 12 Hottest Stock Tips From This Year’s Sohn Experts

It might be time to look beyond big names. That was the message from top fund managers, company founders and super funds at the Sohn Hearts & Minds.

Read More